Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators (Q84301195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Juan José Lasarte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Juan M. Irache

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Carlos Gamazo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

A I Camacho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

R Da Costa Martins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J de Souza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

C Mansilla

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

I Esparza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

7 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

7130-7135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

Pathogen recognition and innate immunity

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Immunomodulatory biomaterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Development of a novel vaccine delivery system based on Gantrez nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

In vitro evaluation of gentamicin released from microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Salmonella-like bioadhesive nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and -independent pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Synthesis of beta-(1-->4)-oligo-D-mannuronic acid neoglycolipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

T-cell regulation: with complements from innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Properdin: emerging roles of a pattern-recognition molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

The role of complement in biomaterial-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

The covalent-binding reaction of complement component C3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

Crosstalk pathways between Toll-like receptors and the complement system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.072

10.1016/J.VACCINE.2011.05.072

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21651945%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference